Haberler      English      العربية      Pусский         Kurdî      Türkçe Delivering News and Insights Around the World Keltis
  En.Haberler.Com - Latest News
SEARCH IN NEWS:
  HOME PAGE 25/11/2020 08:54 
20.11.2020 22:27 News >> Turkey: Pfizer, Biontech Vaccine Tested On Volunteers

Turkey: Pfizer, Biontech Vaccine Tested On Volunteers

At least 40 individuals volunteer for Pfizer BioNTech vaccine trial in northwestern Sakarya province.

At least 40 volunteers received the Pfizer and BioNTech pharmaceutical firms' novel coronavirus vaccine candidate in northwestern Turkey, the head of a medical school in the region said Friday.
In an online statement, Dr. Oguz Karabay, the head of Sakarya University's Faculty of Medicine, said Phase 3 trials of the Pfizer-BioNTech candidate vaccine began and were ongoing on many volunteers across the globe.
The volunteers mainly comprise of health workers and academics, but include others as well, said Karabay.
"The vaccine was administered to 40 volunteers. Satisfactory results have been achieved with the Pfizer-BioNTech company's vaccine. Volunteers who received vaccines are followed up by the Adult Vaccine Polyclinic in the Sakarya Training and Research Hospital infection service," he added.
Karabay further urged everyone to follow the measures against the virus and stressed the importance of personal hygiene, mask wearing, and social distance.
"We're aware that citizens want to help healthcare professionals. So, measures should be followed meticulously and one must not venture outside unless necessary," he said.
US pharmaceutical firm Pfizer and German biotech firm BioNTech announced Wednesday that their coronavirus vaccine candidate "met all of the study's primary efficacy endpoints," and was ready to seek approval from the US Food and Drug Administration "within days."
The announcement marked the first set of complete results from a Phase 3 vaccine trial as the coronavirus has currently infected more than 57.2 million people in 191 countries and regions worldwide.
The final efficacy analysis showed the vaccine was 95% effective against COVID-19 starting 28 days after the first dose, the companies said in a statement.
The coronavirus has claimed 1.36 million lives worldwide and 36.6 million people have recovered since it was first reported last December. -



        Latest News
Ecuador's Interior Minister Dismissed 46 minutes ago...
Maria Paula Romo accused of allowing harsh police intervention during anti government protests in 2019.
Mexico: 113 Bodies Found In Mass Grave 46 minutes ago...
Since 2006, 6,900 corpses have been discovered in 4,092 secret graves nationwide.
Niger's Former President Mamadou Tandja Dies At 82 46 minutes ago...
Government announces three days of national mourning.
Syria Claims Israel Struck Areas South Of Capital 30 minutes ago...
Airstrikes caused only material damage, according to Syrian military.
Anadolu Agency's Morning Briefing – November 25, 2020 15 minutes ago...
Daily briefing on novel coronavirus pandemic worldwide, Turkey, other developments.

 
      Top News
Palestinians Oppose Coordination With Israel: Poll Palestinians Oppose Coordination With Israel: Poll
Libya Lawmakers Hold Consultative Session In Morocco Libya Lawmakers Hold Consultative Session In Morocco
Virus Hits Workers At World's Top Latex Gloves Maker Virus Hits Workers At World's Top Latex Gloves Maker
2 People Killed In Helicopter Crash In Israel 2 People Killed In Helicopter Crash In Israel
66% Of Republicans Want Trump To Run In 2024: Poll 66% Of Republicans Want Trump To Run In 2024: Poll
Burkina Faso Holds Presidential Poll Without Incident Burkina Faso Holds Presidential Poll Without Incident
Cyclone Gati Kills 8 In Somalia Cyclone Gati Kills 8 In Somalia
Turkish Luthier Revives 800 Rare Musical Instruments Turkish Luthier Revives 800 Rare Musical Instruments
Football: Juventus' Turkish Defender Demiral Injured Football: Juventus' Turkish Defender Demiral Injured
US: Biden To Nominate Antony Blinken As State Secretary US: Biden To Nominate Antony Blinken As State Secretary